Investors & Media

Corporate News

• September 03, 2020Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report
• September 01, 2020Annovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial
• August 20, 2020Annovis Bio Actively Recruiting Patients for its Phase 2a Trials in Alzheimer’s and Parkinson’s Diseases

Neurology News

• October 01, 2019Axonal Transport and Neurological Disease
• May 21, 2019How did the amyloid hypothesis go from promising to perilous in the search for Alzheimer’s treatments?
• April 30, 2019After amyloid failures, it’s time to take a new tack for treating Alzheimer’s

MORE NEUROLOGY NEWS